Latest Regulatory Approval News

Cue Energy Resources has advised shareholders to hold off on any action following Horizon Oil's dispatch of a Replacement Bidder’s Statement for its unsolicited takeover offer. A formal response and recommendation from Cue’s Independent Board Committee is expected by early April.

Klevo Rewards’ subsidiary Fly Wallet has gained multi-jurisdictional certification, paving the way for its corporate card programs across 18 international markets.

Theta Gold Mines has locked in a key manufacturing contract for its TGME Gold Project, securing critical equipment that keeps the project on track for commissioning in late 2026 and first gold production early next year.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Ragnar Metals has confirmed high-grade gold extensions at its Harnäs Project in Sweden through recent channel and rock sampling, with drilling preparations now underway following regulatory approvals.

S2 Resources and Black Raven Mining have signed a key Heritage Protection Agreement with the Wajarri Yamaji people, paving the way for exploration licences to be granted over the highly prospective Jillewarra Project in Western Australia.

Sarytogan Graphite Limited has received over $2 million from key investor Dias Sarsenov, advancing its share placement strategy and preparing for a pivotal board appointment. Meanwhile, a significant top-up investment from the EBRD awaits shareholder approval.

Recce Pharmaceuticals is progressing its Phase 3 clinical trial of RECCE 327, a novel synthetic antibiotic targeting multidrug-resistant infections, with interim data from Indonesia supporting registration plans across ASEAN by 2026.

Bass Oil has received regulatory approval to award the drilling contract for its Bunian 6 well in Indonesia, aiming to add 500 barrels of oil per day to current production by mid-year.

Nexalis Therapeutics has initiated dosing in its Phase 1 trial of IRX-616a, a novel cannabidiol inhalation treatment targeting panic disorder. The trial aims to evaluate safety and pharmacokinetics, with dose escalation decisions expected soon.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Horizon Oil has released a first supplementary and replacement bidder’s statement for its off-market takeover offer for Cue Energy, proposing a mix of cash and shares that values Cue at a 10-14% premium. The deal aims to create a diversified oil and gas producer across Asia-Pacific with significant synergies.